Equibles does not estimate personal net worth.
Get an email with a short summary when Maravai Lifesciences Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get MRVI alertsWilliam Martin is recorded as CEO at Maravai Lifesciences Holdings, Inc. (MRVI). The newest filing on record that lists William Martin as CEO at Maravai Lifesciences Holdings, Inc. (MRVI) is dated April 24, 2026. The proxy statement of Maravai Lifesciences Holdings, Inc. reports total compensation of $6,380,399 for William Martin in fiscal 2024, including a base salary of $775,385. Disclosed compensation is on record for 3 fiscal years. William Martin has spoken on 1 earnings call across 1 company, most recently for Maravai Lifesciences Holdings, Inc. on May 8, 2024. Maravai Lifesciences Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Maravai Lifesciences Holdings, Inc. includes Bernd Brust (CEO and Board Member), William "Trey" Martin, III (CEO and Board Member), William E. Martin III (CEO) and 7 others.
“We appreciate having you join us for our call today. Let me briefly recap the quarter, highlight some innovative new products we are introducing, and provide a few business updates before turning the call over to Kevin.”
Start not stated–present
Last confirmed April 24, 2026
Proxy statement
Start not stated–2023-04-20
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Maravai Lifesciences Holdings, Inc. (MRVI) | Chief Executive Officer | $775,385 | $6,380,399 |
| 2023 | Maravai Lifesciences Holdings, Inc. (MRVI) | Chief Executive Officer | $750,000 | $2,301,864 |
| 2022 | Maravai Lifesciences Holdings, Inc. (MRVI) | Chief Executive Officer | $660,385 | $14,523,493 |
